000 01405 a2200409 4500
005 20250518063009.0
264 0 _c20200615
008 202006s 0 0 eng d
022 _a1520-4804
024 7 _a10.1021/acs.jmedchem.9b01283
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFindlay, Alison D
245 0 0 _aIdentification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_c11 2019
300 _a9874-9889 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmines
_xchemistry
650 0 4 _aAnimals
650 0 4 _aDrug Design
650 0 4 _aEnzyme Inhibitors
_xchemistry
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aProtein-Lysine 6-Oxidase
_xantagonists & inhibitors
650 0 4 _aTriazoles
_xchemistry
700 1 _aFoot, Jonathan S
700 1 _aBuson, Alberto
700 1 _aDeodhar, Mandar
700 1 _aJarnicki, Andrew G
700 1 _aHansbro, Philip M
700 1 _aLiu, Gang
700 1 _aSchilter, Heidi
700 1 _aTurner, Craig I
700 1 _aZhou, Wenbin
700 1 _aJarolimek, Wolfgang
773 0 _tJournal of medicinal chemistry
_gvol. 62
_gno. 21
_gp. 9874-9889
856 4 0 _uhttps://doi.org/10.1021/acs.jmedchem.9b01283
_zAvailable from publisher's website
999 _c30169876
_d30169876